A myasthenia gravis treatment revolution has taken place in the past four years, spurred by an initial approval for argenx’s ...
Gorlin Syndrome, also known as Nevoid Basal Cell Carcinoma Syndrome, is a rare inherited genetic disorder affecting 1 in 31,000 people worldwide that can develop 500-1000 Basal Cell Carcinoma (BCC) ...
All primary and secondary interim analysis endpoints in FORTIFY Phase 3 study successfully achieved with well-tolerated ...
Dr. Reddy’s Laboratories is a buy, with key growth in biosimilars and GLP-1 segments. Click here to read my most recent ...
Medicus Pharma Ltd. (NASDAQ: MDCX) ("Medicus" or the "Company"), a biotech/life sciences company focused on advancing the clinical development programs of novel and potentially disruptive therapeutics ...
Q3 2025 Earnings Call Transcript October 28, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $3, expectations were $2.98. Operator: Ladies and gentlemen, thank you for standing ...
As Nvidia pushes forward on its ambitions in artificial intelligence, the computing giant is lining up partnerships with tech ...
In a pop-up city off the coast of Honduras, longevity startups are trying to fast-track anti-aging drugs. Is this the future ...
Hair growth and loss prevention is a big industry. Market intelligence agency Business Research Insights projected it to hit ...
Q3 2025 Earnings Call October 29, 2025 10:00 AM EDTCompany ParticipantsBreno Pires de Oliveira - Chief Executive ...
Berninger patted himself down, dug a hand into seat pockets and any bag he could find. No notebook. Resorting to his cell ...
On today’s Playbook Podcast: Jack and Dasha discuss the prospect (or otherwise) of a third term for Donald Trump, what he’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback